Glomerulosclerosis, Focal Segmental - 25 Studies Found
Completed |
: A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) : Glomerulosclerosis, Focal Segmental : 2013-11-27 : Drug: Losmapimod Losmapimod (micronized GW856553X) will be supplied as a film coated white, 7 mm round, |
Completed |
: Sirolimus for Focal Segmental Glomerulosclerosis : Focal Glomerulosclerosis : 2002-06-26 : Drug: Sirolimus |
Terminated |
: Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS) : Focal Segmental Glomerulosclerosis : 2008-10-27 : Drug: FG-3019 FG-3019 5 mg/kg IV given over 2 hours every 2 weeks for 8 weeks |
Terminated |
: Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis : Focal Segmental Glomerulosclerosis : 2009-08-10 :
|
Completed |
: Permeability Factor in Focal Segmental Glomerulosclerosis : Focal Segmental Glomerulosclerosis : 2000-12-22 :
|
Recruiting |
: Genetic Markers for Focal Segmental Glomerulosclerosis :
|
Recruiting |
: Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis :
|
Completed |
: Rituximab Treatment of Focal Segmental Glomerulosclerosis : Focal Segmental Glomerulosclerosis (FSGS) : 2007-10-26 : Drug: rituximab 375 mg/m2 intravenously for 4 doses |
Active, not recruiting |
: Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis : Focal Segmental Glomerulosclerosis : 2012-06-04 :
|